Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Marks, M.D.

Concepts (37)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jennifer Marks's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jennifer Marks has written about over time.
Alphapapillomavirus, 1 publications between 2021 and 2021, average publication date January 2021. Carcinoma, Squamous Cell, 1 publications between 2021 and 2021, average publication date January 2021. Head and Neck Neoplasms, 1 publications between 2021 and 2021, average publication date January 2021. Oropharyngeal Neoplasms, 1 publications between 2021 and 2021, average publication date January 2021. Papillomavirus Infections, 1 publications between 2021 and 2021, average publication date January 2021. Genes, T-Cell Receptor, 1 publications between 2021 and 2021, average publication date July 2021. Lymphoma, T-Cell, Cutaneous, 1 publications between 2021 and 2021, average publication date July 2021. Skin Neoplasms, 1 publications between 2021 and 2021, average publication date July 2021. Oculomotor Nerve Diseases, 1 publications between 2022 and 2022, average publication date September 2022. Antineoplastic Agents, 1 publications between 2022 and 2022, average publication date October 2022. Immunoconjugates, 1 publications between 2022 and 2022, average publication date October 2022. Leukemia, Myeloid, Acute, 1 publications between 2023 and 2023, average publication date February 2023. Myelodysplastic Syndromes, 1 publications between 2023 and 2023, average publication date February 2023. Myeloproliferative Disorders, 1 publications between 2023 and 2023, average publication date February 2023. Carcinoma, Non-Small-Cell Lung, 2 publications between 2022 and 2024, average publication date September 2023. Lung Neoplasms, 2 publications between 2022 and 2024, average publication date September 2023. Mutation, 2 publications between 2023 and 2024, average publication date November 2023. Exons, 1 publications between 2024 and 2024, average publication date September 2024. Proto-Oncogene Proteins c-met, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Marks's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (37)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.